... on number ofbrain metastases. Elaimy et al. World Journal of Surgical Oncology 2011, 9:69http://www.wjso.com/content/9/1/69Page 5 of 9 brain metastases, and tumor volume ofbrain metastases. The ... tumor histology,number ofbrain metastases, and volume ofbrain metas-tases have on the survival of patients diagnosed with brain metastases. Multivariate analysis oftreatment regi-mens showed ... 4). Treatment regimens were prescribed based on thepatient’ s performance status, age, control of primary cancer, presence of extracranial disease, number of brain metastases, size ofbrain metastases, ...
... Details of Irinotecan DC/LC Bead Treatment. Variable patients NN of treatments = 99Total # of patients = 55One treatment 55(100%)Two treatments 28 (50%)Three treatments 12(9%)≥Four treatments ... the date of diagnosis of metastases was 3.4 years the median survival time from the start of TACE treatment was 1.34 years. The mediansurvival time of the palliative group was 1.4 years, of thesymptomatic ... here:http://www.biomedcentral.com/info/publishing_adv.aspBioMedcentralWorld Journal of Surgical Oncology 2009, 7:80 http://www.wjso.com/content/7/1/80Page 12 of 12(page number not for citation purposes) Treatment of Cancer, National Cancer Institute of theUnited...
... exhaust gas treatment. They were devided into two categories: treatments of single pollutant and simultaneous treatmentof pollutants. 1.2.1 Separated treatmentof pollutants 1.2.1.1 CO treatments ... Composition of exhaust gas 13 1.2 Treatments of air pollution 14 1.2.1 Separated treatmentof pollutants 14 1.2.1.1 CO treatments 14 1.2.1.2 VOCs treatments 14 1.2.1.3 NOx treatments 14 ... activity of three-way catalysts based on mixed metal oxides for the treatmentof exhaust gases from internal combustion engine Nguyen The Tien 3 CONTENT OF THESIS LIST OF TABLES 6 LIST OF FIGURES...
... metastasis from SCC of the cervix is an extremely uncommon ‘malignant’ cause of upper gastrointestinal bleeding. Yet, accurate recognition of such unusual patterns ofmetastases in cervical cancer ... USA only 0.4% of all cancers are in the small bowel, making up 0.2% of all cancer- related deaths [1]. Malignant tumors of the small bowel are unusual, and account for only 1-5% of all GI tract ... confirming the duodenal metastases. The clinical presentation of a ‘malignant' upper-gastrointestinal bleed due to duodenal metastases from SCC of the cervix is unusual. Awareness of such infrequent...
... success of chemotherapywill hinge on the development of new agents that haveimproved penetration into CNS.CNS effects ofradiationtherapy for brain metastases WBRT, the standard of care for brain ... be used as a marker of neu-ronal damage. Elevated levels have been found in patientswith brainmetastasesfrom both small cell lung cancer and non-small cell lungcancer (NSCLC) [76]. A multi-center ... current management ofbrain metastases, summarize the data on the CNS effects associated with brainmetastases and whole brain radiation therapy in these patients, discuss the use of neuropsychological...
... trial comparing two types of consolidationchemotherapy after concurrent chemoradiotherapy for limited-disease small cell lung cancer. RTrequirements included a total dose of 45 Gy/30 fx (bis in ... 60% of the cases [6].JCOG 0202 was a multi-center phase III trial comparingtwo types of consolidation chemotherapy after concurrentchemoradiotherapy for limited-disease small cell lung cancer ... 1 of 5(page number not for citation purposes) Radiation OncologyOpen AccessResearchRadiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung...
... with NSCLC 14 1.5 Radical radiotherapy alone for treatmentofNSCLC 15 1.6 Chemotherapy for patients with NSCLC 15 1.7 Combination treatment for NSCLC 16 1.8 Treatmentof small-cell lungcancer ... men, who account for 60% oflungcancer cases. In women, lungcancer is the second most common cause ofcancer death after breast cancer. Survival rates for lungcancer are very poor. In England, ... than those of the USA. Lung cancers are classified into two main categories: small-cell lung cancers (SCLC), which account for about 20% of cases, and non-small-cell lung cancers (NSCLC) , which...
... immunotoxinsconstructed from Pseudomonas exotoxin A for the treatment of cancer John E. Weldon and Ira PastanLaboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, ... 50% (7 ⁄ 14) of patientsshowed a partial response to treatment. The future of PE-based RITsMany obstacles have been overcome in the develop-ment of RITs for the treatmentof cancer, and strikingresponses ... variety of ways, from changing the number of receptor sites per cell to altering the rate of internali-zation of the receptor or influencing the intracellulartrafficking. The proteome of the target...
... revealing various spectral peaks oflung cancer cell lines to better discriminate between the normal and lungcancer cells. The vibrational spectra oflung cancer cells were analyzed by attenuated ... phosphorylationIntroduction Cancer is the principal causes of death worldwide according to the World Health Organization, with lungcancer being one of the most commonly diagnosed types ofcancer in men ... Korea The vibrational spectral differences of normal and lung cancer cells were studied for the development of effective cancer cell screening by means of attenuated total reflection infrared...
... dosimetric comparison of MammoSite high-dose-ratebrachytherapy and Xoft Axxentđ electronic brachytherapy. Brachytherapy2007, 6:164-168.19. Dickler A: Xoft Axxentđ electronic brachytherapy: a new ... perspectives from aprospective, nonrandomized, multicenter study of breast conservingsurgery and adjuvant electronic brachytherapy for the treatment of breast cancer. World Journal of Surgical ... char-acteristics of both groups are shown in Table 2. Themajority of patients were post-menopausal Caucasianwomen with no prior history ofcancer and no familyhistory of breast cancer. The study...
... diagnosis and in the monitoring of response to systemic therapy) , and identification of thepattern of changes of serum FA-2 levels in relation to bis-phosphonate therapy and events such as hypercalcaemiaare ... markers. Br J Cancer 1991, 64:757-63.6. Dixon AR: Tumour markers - a logical approach to the guidance of therapy in advanced breast cancer? In Doctor of Medicine Thesis University of Nottingham; ... be the circulating form of the aminopropeptide of the alpha 1 chain of procollagen type I. Serum concentrations of FA-2 appeared to be elevated in a number of disorders of bone metabolism. This...
... 1Department ofRadiation Therapy, Catharina Hospital, Eindhoven, The Netherlands, 2Department ofRadiation Oncology, VU University Medical Center, Amsterdam, The Netherlands, 3Department ofRadiation ... broad overview of all the tech-nical aspects of stereotactic radiotherapy for early stage lung cancer. Our aim was to develop widely applicableguidelines in view of the number of stereotactic ... for lung tumour treatment plans, and generally increase with decreasing field size,which is especially relevant in stereotactic radiotherapy of stage 1A lung tumours. Thus, depending on the treatment planning...